CTHRC1 is a prognostic biomarker correlated with immune infiltration in head and neck squamous cell carcinoma DOI Creative Commons
Zhichao Zhang, Xusheng Ren, Yiling Wang

и другие.

BMC Oral Health, Год журнала: 2024, Номер 24(1)

Опубликована: Июнь 27, 2024

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy worldwide, characterized by high morbidity, mortality, poor prognosis. Collagen triple helix repeat containing 1 (CTHRC1) has been shown to be highly expressed in various cancers. However, its biological functions, potential role as a biomarker, relationship with immune infiltrates HNSCC remain unclear. Our principal objective was analyze CTHRC1 expression, prognostic implications, effects on system patients using bioinformatics analysis.

Язык: Английский

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition DOI Creative Commons
Antonino Glaviano,

Hannah Lau,

Lukas M. Carter

и другие.

Journal of Hematology & Oncology, Год журнала: 2025, Номер 18(1)

Опубликована: Янв. 13, 2025

The tumor microenvironment (TME) is integral to cancer progression, impacting metastasis and treatment response. It consists of diverse cell types, extracellular matrix components, signaling molecules that interact promote growth therapeutic resistance. Elucidating the intricate interactions between cells TME crucial in understanding progression challenges. A critical process induced by epithelial-mesenchymal transition (EMT), wherein epithelial acquire mesenchymal traits, which enhance their motility invasiveness progression. By targeting various components TME, novel investigational strategies aim disrupt TME's contribution EMT, thereby improving efficacy, addressing resistance, offering a nuanced approach therapy. This review scrutinizes key players emphasizing avenues therapeutically components. Moreover, article discusses implications for resistance mechanisms highlights current toward modulation along with potential caveats.

Язык: Английский

Процитировано

26

Interplay between MRI radiomics and immune gene expression signatures in oral squamous cell carcinoma DOI Creative Commons
Anna Corti, Deborah Lenoci, Valentina Corino

и другие.

Scientific Reports, Год журнала: 2025, Номер 15(1)

Опубликована: Апрель 12, 2025

With the advances in immunotherapy and challenge of poor responsiveness oral squamous cell carcinoma (OSCC) patients, understanding tumor microenvironment is crucial. Radiogenomics offers potential to provide pre-operative, non-invasive image-derived immune biomarkers. To this aim, present study explores capability MRI-based radiomics describe patients' state OSCC. Seven radiomic, 29 immune-related gene expression signatures were computed deconvolution analysis was performed for a subset OSCC from BD2Decide database. A correlation-driven identified key associations between radiomic populations. Radiomic classifiers then developed evaluate their stratify patients based on status. models showed promising results predicting signature associated with significant prognostic value HNSCC who underwent radiotherapy (AUC = 0.92), suggesting these models' distinguishing radioresistant radiosensitive aiding treatment decisions. Additionally, reflected infiltrating cells our cohort (M1, CD8 + T, B cells). MRI-radiomic could become methods prognosis choice patients. Based results, upon external validation, MRI-radiomics enhance personalized medicine approaches.

Язык: Английский

Процитировано

0

Advances and challenges in CAR-T cell therapy for head and neck squamous cell carcinoma DOI Creative Commons

Sahand Saeidpour Masouleh,

Kamyar Nasiri,

Ava Ostovar Ravari

и другие.

Biomarker Research, Год журнала: 2025, Номер 13(1)

Опубликована: Май 1, 2025

Язык: Английский

Процитировано

0

Comprehensive analysis of stearoyl-coenzyme A desaturase in prostate adenocarcinoma: insights into gene expression, immune microenvironment and tumor progression DOI Creative Commons
Jie Wang, Ying Liang,

He Xiong

и другие.

Frontiers in Immunology, Год журнала: 2024, Номер 15

Опубликована: Сен. 16, 2024

Prostate adenocarcinoma (PRAD) is a prevalent global malignancy which depends more on lipid metabolism for tumor progression compared to other cancer types. Although Stearoyl-coenzyme A desaturase (SCD) documented regulate in multiple cancers, landscape analysis of its implications PRAD are still missing at present. Here, we conducted an diverse datasets revealing elevated SCD expression the cohort both mRNA and protein levels. Interestingly, was associated with promoter hypermethylation genetic alterations, notably L134V mutation. Integration comprehensive immunological genomic data revealed robust positive correlation between levels abundance CD8 + T cells macrophages. Further analyses identified significant associations various immune markers microenvironment. Single-cell transcriptomic profiling unveiled differential patterns across distinct cell types within prostate The Gene Ontology Kyoto Encyclopedia Genes Genome showed that enriched pathways were primarily related biosynthesis, cholesterol endoplasmic reticulum membrane functions, metabolic pathways. Set Enrichment Analysis highlighted involvement crucial cellular processes, including cycle biosynthesis cofactors In functional studies, overexpression promoted proliferation, metastasis invasion cells, whereas downregulation inhibits these processes. This study provides insights into multifaceted roles pathogenesis, underscoring potential as therapeutic target prognostic biomarker.

Язык: Английский

Процитировано

3

Bioinformatics-Based Analysis of the Relationship between Tumor-Infiltrating Immune Cells and the Prognosis of Head and Neck Squamous Cell Carcinoma DOI

禾怡 杨

Hans Journal of Biomedicine, Год журнала: 2024, Номер 14(04), С. 573 - 582

Опубликована: Янв. 1, 2024

Язык: Английский

Процитировано

0

CTHRC1 is a prognostic biomarker correlated with immune infiltration in head and neck squamous cell carcinoma DOI Creative Commons
Zhichao Zhang, Xusheng Ren, Yiling Wang

и другие.

BMC Oral Health, Год журнала: 2024, Номер 24(1)

Опубликована: Июнь 27, 2024

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy worldwide, characterized by high morbidity, mortality, poor prognosis. Collagen triple helix repeat containing 1 (CTHRC1) has been shown to be highly expressed in various cancers. However, its biological functions, potential role as a biomarker, relationship with immune infiltrates HNSCC remain unclear. Our principal objective was analyze CTHRC1 expression, prognostic implications, effects on system patients using bioinformatics analysis.

Язык: Английский

Процитировано

0